Skip to content

Proto Labs

US · PRLB #2685 by market cap Listed 1970
57.52 -5.37 -8.54%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Fair Value how this is computed

Near fair value
10.69 fair value ≈ 36.52 62.35
  • Implied fair-value range of 10.69-62.35, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +57.5% above the average-multiple fair value of 36.52.

Valuation each multiple against its own 5-year range

P/B ratio 2.30 Expensive vs history 89th percentile
5-year average 1.56 · #11 of 17 in Metal Fabrication
P/E ratio 46.91 In line with history 58th percentile
5-year average 41.50 · forward 34.11 · #9 of 10 in Metal Fabrication
P/S ratio 2.78 Expensive vs history 79th percentile
5-year average 2.19 · forward 2.59 · #14 of 17 in Metal Fabrication

Vs. peers Metal Fabrication

Company Market cap P/E (TTM) P/B Div yield
Proto Labs (PRLB) 1.37B 39.94 1.96 0.00%
ATI Inc (ATI) 22.49B 41.40 11.22 0.00%
Carpenter Technology (CRS) 12.58B 22.40 5.76 0.31%
Mueller Industries (MLI) 10.87B 12.78 3.09 1.30%
Commercial Metals (CMC) 5.99B 9.30 1.28 1.40%
ESAB Corp (ESAB) 4.65B 30.51 1.95 0.59%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value70.81 Economic moatNarrow UncertaintyMedium

Trading 23.1% below Morningstar's fair value estimate.

Fair value

Proto Labs Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 5% discount to our quantitative fair value estimate of $70.81 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The firm's balance sheet bolsters our valuation estimate. Low leverage mitigates financial risk, potentially boosting a firm's value. Reflecting the firm's leverage is its debt to EBITDA ratio of 0.04, which lies in the bottom 10% globally. Without much debt relative to assets, this company should exhibit high resilience should the global economy weaken; if not, the company could raise debt and invest in the business or return capital to shareholders. We believe this is a sign that shares could be cheap.

Alternatively, the firm's unfavorable dividend structure is potentially concerning. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, ranks in the bottom 30% compared with global peers. This could imply a planned dividend cut or relatively high share price, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.

Proto Labs discussion 0 comments

Add a comment